Intracerebral de novo arterio-venous malformations as a side effect of bevacizumab
Journal of Oncology Pharmacy Practice
Published online on April 20, 2023
Abstract
Journal of Oncology Pharmacy Practice, Volume 32, Issue 3, Page 577-581, April 2026.
IntroductionBevacizumab is a monoclonal antibody for the vascular endothelial growth factor receptor and is utilized in the treatment of various tumors. Gastrointestinal perforation/fistula, heart failure, hemorrhage, hypertension, proteinuria/nephrotic ...
IntroductionBevacizumab is a monoclonal antibody for the vascular endothelial growth factor receptor and is utilized in the treatment of various tumors. Gastrointestinal perforation/fistula, heart failure, hemorrhage, hypertension, proteinuria/nephrotic ...